Clinical Trials Logo

Polycystic Ovary Syndrome clinical trials

View clinical trials related to Polycystic Ovary Syndrome.

Filter by:

NCT ID: NCT04452968 Completed - Weight Loss Clinical Trials

Comparison of Intermittent Fasting and Caloric Deficit for Weight Loss in Women With Polycystic Ovarian Syndrome

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Time restricted feeding (TRF) has been emerging as a potential weight loss strategy that avoids major dietary changes but achieves strong effects. It also improves insulin sensitivity through increased human growth hormone. This effect helps to improve the root cause of weight gain and has additional benefits for women with PCOS.

NCT ID: NCT04448730 Completed - Obesity Clinical Trials

Polycystic Ovary Syndrome and BETATROPHIN

Start date: January 1, 2018
Phase:
Study type: Observational

This is an original study giving an information about the association body mass index, polycystic ovary syndrome and betatrophin.

NCT ID: NCT04425083 Completed - Clinical trials for Polycystic Ovary Syndrome

Relationship of the Chinese Medical Constitution & Syndromes in Patients With Polycystic Ovary Syndrome

Start date: November 18, 2015
Phase:
Study type: Observational

This study is a cross-sectional study. The purpose is to understand the characteristics of Chinese medicine constitutional syndrome in patients with polycystic ovary. In addition, the health-related quality of life (SF-36), mental state (stress, depression) of patients with polycystic ovary , Anxiety) and the relationship between hormone biochemical indicators and TCM constitutional syndromes, to develop a pioneering study on TCM constitution diagnosis and life guidelines for polycystic ovarian patients and future clinical adjuvant therapy.

NCT ID: NCT04416620 Completed - Clinical trials for Polycystic Ovary Syndrome

The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The primary aim of this study was to estimate the prevalence of anxiety disorder and depression amongst Syrian and Jordanian women who are suffering from PCOS in Damascus and Amman. The secondary aim was to assess the effectiveness of a PCOS pharmaceutical care service on selected patient's biochemical parameters, QOL, anxiety, and depression scale. The third aim is to identify the factors associated with QOL, anxiety and depression scores' change across the study. Null Hypothesis (research hypothesis): The intervention of PCOS pharmaceutical care service will lead to no significant differences in patient's depression, anxiety, QOL, and some biochemical parameters in comparison to females who will not receive this intervention in both Syria and Jordan. Alternative Hypothesis (research hypothesis): The intervention of PCOS pharmaceutical care service will have a significant impact on patient's depression, anxiety, QOL, and some biochemical parameters in comparison to patients who will not receive this intervention in both Syria and Jordan.

NCT ID: NCT04398186 Completed - Clinical trials for Polycystic Ovary Syndrome

The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function

Start date: June 1, 2020
Phase:
Study type: Observational [Patient Registry]

Polycystic Ovarian Syndrome (PCOS) is the most common endocrinological disorder in women of reproductive age, and its prevalence is reported to be 6-21% in women aged 15-49 (1). Although its etiopathogenesis is still not clear, it is known that it is due to the disregulation of ovarian steroidogenesis under the influence of some environmental and genetic factors. Diagnosis of ESHRE / ASRM has set Rotterdam criteria in 2003; one of these criteria is the presence of hyperandrogenism (2). Hyperandrogenism leads to an increase in general muscle mass in the body (1, 3, 4). Pelvic floor muscles are associated with urethra in the anterior compartment, rectum and anus in the posterior compartment, and uterine support in the apex; major urinary and fecal continence ensuring its functions in order to stop in the appropriate position of the pelvic organs (5). The well-being of the pelvic floor muscle strength has a protective effect from urinary and fecal incontinence. It has been emphasized that the "anogenital distance" determined by the measurement of the anal region anterior to the clitoris anterior may also be a criteria in the diagnosis of Polycystic Ovary Syndrome (7,8,9). In this study, patients in the reproductive age between 18-40 years, who applied to our gynecology outpatient clinic and were diagnosed as PCOS according to Rotterdam criteria wil be study gorup and the women without PCOS will be control group. We aimed to evaluate the pelvic muscle strength with perineometry, to measure anogenital distance and to determine possible relationships with each other. In addition to demographic information, ICIQ-SF (Urinary incontinence inquiry short form) will also be taken to evaluate pelvic floor function (10).

NCT ID: NCT04369248 Completed - Obesity Clinical Trials

Hepassocin Levels in Patients With Polycystic Ovary Syndrome

Start date: January 3, 2020
Phase:
Study type: Observational

The investigators aimed to investigate hepassocin levels in patients with polycystic ovary syndrome (PCOS). There are 3 groups aged between 18 and 35 years as non-obese healthy women, non-obese women with PCOS, and obese women (BMI>30) with PCOS.

NCT ID: NCT04365686 Completed - Smooth Extubation Clinical Trials

Smooth Extubation With Ketofol for Induction of General Anesthesia in Laparoscopic Drilling of Polycystic Ovary

Start date: April 1, 2019
Phase: Phase 4
Study type: Interventional

the effect of ketofol, a combination of propofol and ketamine, on hemodynamics and airway response during induction of general anesthesia has been studied before. Its effect on the smoothness of extubation has not been studied before. In the present study; we aimed to assess the effect of ketofol on the smoothness of extubation as regards, airway response, sedation score during suction and extubation and hemodynamic changes comparing it with propofol for induction of general anesthesia.

NCT ID: NCT04264832 Completed - Clinical trials for Polycystic Ovary Syndrome (PCOS)

Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome

Start date: March 1, 2016
Phase:
Study type: Observational

To investigate the body fat distribution in chinese women with polycystic ovary syndrome (PCOS) and the association of those distribution with metabolic parameters, microeconomics, hormone profiles and psychological state.

NCT ID: NCT04238078 Completed - Clinical trials for Polycystic Ovary Syndrome

Taste Function and Eating Habits in Polycystic Ovary Syndrome

Start date: January 15, 2020
Phase:
Study type: Observational

This study evaluates taste function and eating habits in patients with PCOS compared to healthy women and before and after oral contraceptive use.

NCT ID: NCT04231786 Completed - Breast Diseases Clinical Trials

Breast Ultrasonography and Polycystic Ovary Syndrome

Start date: January 14, 2020
Phase:
Study type: Observational [Patient Registry]

The results of the evaluation of breast ultrasonography results of patients with polycystic ovary syndrome diagnosis over 30 years of age will be evaluated. Patients admitted to the outpatient clinic and rotterdam criteria according to laboratory data and polycystic ovary syndrome patients diagnosed by the same radiologist the next day after the end of menstrual breast ultrasonography. The aim of this study is to show the association of polycystic ovary syndrome and fibrocystic breast.